Amarin Corp AMRN

Jump To Section

    $

    9
    8
    7
    6
    5
    4
    3
    2
    1
    0
    0
    9
    8
    7
    6
    5
    4
    3
    2
    1
    0
    0
    .
    9
    8
    7
    6
    5
    4
    3
    2
    1
    0
    0
    -$0.01 (-0.99%)Past DayToday's Volume:
    9
    8
    7
    6
    5
    4
    3
    2
    1
    0
    0
    9
    8
    7
    6
    5
    4
    3
    2
    1
    0
    0
    9
    8
    7
    6
    5
    4
    3
    2
    1
    0
    0
    ,
    9
    8
    7
    6
    5
    4
    3
    2
    1
    0
    0
    9
    8
    7
    6
    5
    4
    3
    2
    1
    0
    0
    9
    8
    7
    6
    5
    4
    3
    2
    1
    0
    0

    Relative Strength Index (RSI)

    - The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. It is typically used to identify overbought or oversold conditions in financial markets.

    - The RSI is calculated using the following formula:

    RSI = 100 - (100 / (1 + RS))

    Where RS is the ratio of the average gains to the average losses over a specified period.

    - The default time period used is 14 days.

    - RSI values range between 0 and 100.

    RSI values above 70 are considered overbought (indicating a potentially opportune time to sell)

    RSI values below 30 are considered oversold (indicating a potentially opportune time to buy)

    RSI is not a perfect indicator and should be used in conjunction with other technical analysis tools, this is for informational purposes only and is not a substitute for professional financial advice.

    About

    Business overview of Amarin Corp (AMRN)
    Amarin Corp PLC is a biopharmaceutical company. It is focused on the commercialization and development of therapeutics to improve cardiovascular, or CV, health and reduce CV risk. Its commercialized product includes Vascepa.

    Key Insights

    Critical company metrics and information

    • Latest Closing Price

      $0.53

    • Market Cap

      $218.01 Million

    • Price-Earnings Ratio

      -5.30

    • Total Outstanding Shares

      411.34 Million Shares

    • Total Employees

      275

    • Dividend

      No dividend

    • IPO Date

      April 1, 1993

    • SIC Description

      Pharmaceutical Preparations

    • Primary Exchange

      NASDAQ

    • Type

      American Depository Receipt Common

    • Headquarters

      Spaces south docklands, block c, Dublin 2, L2, D02 VK60

    • Homepage

      https://www.amarincorp.com

    Historical Stock Splits

    If you bought 10 shares of AMRN before January 18, 2008, you'd have 1 share today.
    Execution DateSplit Amount
    January 18, 20081-for-10 (Reverse Split)

    Cash Flow Statement

    October 1, 2023 to September 30, 2024
    MetricValue
    Net Cash Flow From Financing Activities$-1.38 Million
    Net Cash Flow$-113.87 Million
    Net Cash Flow, Continuing$-113.87 Million
    Net Cash Flow From Operating Activities, Continuing$-18.36 Million
    Net Cash Flow From Investing Activities$-94.14 Million
    Net Cash Flow From Financing Activities, Continuing$-1.38 Million

    Income Statement

    October 1, 2023 to September 30, 2024
    MetricValue
    Basic Average Shares$410.95 Million
    Operating Expenses$180.19 Million
    Research and Development$20.68 Million
    Costs And Expenses$270.76 Million
    Participating Securities, Distributed And Undistributed Earnings/Loss, Basic$0
    Diluted Average Shares$410.95 Million

    Comprehensive Income

    October 1, 2023 to September 30, 2024
    MetricValue
    Comprehensive Income/Loss Attributable To Noncontrolling Interest$0
    Comprehensive Income/Loss$-39.35 Million
    Other Comprehensive Income/Loss$0
    Comprehensive Income/Loss Attributable To Parent$-39.35 Million

    Balance Sheet

    October 1, 2023 to September 30, 2024
    MetricValue
    Inventory$224 Million
    Noncurrent Assets$100.40 Million
    Fixed Assets$24,000
    Other Current Assets$426.22 Million
    Current Assets$650.22 Million
    Liabilities And Equity$750.62 Million

    Historical Dividends

    Announcement DatePayment DateRecord DateAmountFrequency
    No historical dividends

    Recent Headlines From The Web

    Latest news, press releases, and media coverage about AMRN from trusted financial sources
      Boost your savings and earn 4.15% APY with a Marcus by Goldman Sachs savings account, a rate that's 8x the national averagewhen signing up with Financhle. No fees, no minimum deposits, backed by the financial expertise of Goldman Sachs. Terms apply.
      All TickersEarnings CalendarNews ArticlesAbout UsPrivacy & Cookies Info

      â“’ 2025 Financhle. All Rights Reserved.